Lithium Borohydride Reduction of Ester Intermediates
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing (S)-(+)-2-(substituted phenyl)-2-hydroxy-ethyl carbamates are inefficient and require multiple steps with high reagent usage, leading to increased costs and complexity in producing compounds useful for treating central nervous system disorders like epilepsy.
Innovation Solution
A process involving lithium borohydride reduction of an ester intermediate, followed by esterification and protection steps using phosphorous oxychloride and ether-derived protecting groups, simplifies the synthesis and reduces reagent requirements, improving yield and safety.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional methods are used to prepare (S)-(+)-2-(substituted phenyl)-2-hydroxy-ethyl carbamates, then the synthesis can be completed, but the process requires multiple steps with high reagent usage, leading to increased costs and complexity
Solution Approach 1:
The patent combines multiple synthesis steps into a single step by using phosphorous oxychloride to achieve both esterification and protection in one operation. This merging of operations reduces the number of steps from conventional multi-step procedures to a streamlined single-step process, directly addressing the complexity issue while maintaining manufacturing feasibility
Solution Approach 2:
Phosphorous oxychloride serves multiple functions simultaneously: it acts as a coupling agent for esterification, provides acidic catalysis for protection, and eliminates the need for separate reagents. This multi-functionality reduces both the number of steps and reagent usage, resolving the contradiction between ease of manufacture and process complexity
2Ease of manufacture
If conventional methods are used to prepare (S)-(+)-2-(substituted phenyl)-2-hydroxy-ethyl carbamates, then the synthesis can be completed, but reagent usage is high, leading to increased costs
Solution Approach 1:
The patent changes the chemical parameters by using phosphorous oxychloride instead of conventional reagents, which alters the reaction efficiency and selectivity. This parameter change enables the reaction to proceed with higher efficiency, reducing reagent consumption while maintaining production feasibility through optimized reaction conditions
Solution Approach 2:
The patent converts the potentially harmful side reactions into beneficial selective reactions by using phosphorous oxychloride, which provides acidic catalysis that directs the reaction toward the desired product. This converts what would normally be harmful non-selective reactions into beneficial selective transformations, reducing waste while maintaining production feasibility
3Ease of manufacture
If conventional methods are used to prepare (S)-(+)-2-(substituted phenyl)-2-hydroxy-ethyl carbamates, then the synthesis can be completed, but cycle time is increased
Solution Approach 1:
By merging multiple sequential steps into a single simultaneous operation using phosphorous oxychloride, the patent eliminates the time required for separate esterification and protection steps. This temporal consolidation reduces cycle time while maintaining production capability through the efficient single-step process
Solution Approach 2:
The patent achieves continuous useful action by having phosphorous oxychloride perform multiple functions simultaneously in one reaction vessel, eliminating idle time between steps. The reaction proceeds continuously through esterification and protection in a single operation, maximizing productivity while reducing overall cycle time
4Ease of manufacture
If conventional methods are used to prepare (S)-(+)-2-(substituted phenyl)-2-hydroxy-ethyl carbamates, then the synthesis can be completed, but side reactions increase, reducing yield
Solution Approach 1:
The patent converts non-selective side reactions into selective desired reactions by using phosphorous oxychloride, which provides acidic catalysis that directs the reaction toward the target product. This transforms harmful non-selective chemistry into beneficial selective transformations, improving yield while maintaining production viability
Solution Approach 2:
The patent changes the chemical parameters by introducing phosphorous oxychloride as a coupling agent and acidic catalyst, which alters the reaction pathway to be more selective. This parameter change enhances manufacturing precision by directing the reaction toward the desired product while suppressing side reactions, thereby improving yield
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process enhances the efficiency and selectivity of producing (S)-carbamic acid 2-(2-chloro-phenyl)-2-hydroxy-ethyl ester, reducing reagent usage, cycle time, and side reactions, while increasing yield and safety, making it more viable for pharmaceutical applications.
Implementation Method 1
c) reduction of the ester intermediate of Formula II, to an alcohol of Formula III, wherein said reduction is characterized by the use of lithium borohydride
Implementation Method 2
a) esterification of (S)-(2-chloro-phenyl)-hydroxy-acetic acid, (S)-(2-chloro-phenyl)-hydroxy-acetic acid with a C(1-4)alcohol, selected from the group consisting of: methanol, ethanol, n-propanol, iso-propanol, n-butanol, iso-butanol, sec-butanol, and tert-butanol: wherein said esterification is characterized by the use of: 0.025 to 0.4 equivalents phosphorous oxychloride
Implementation Method 3
b) protection of the alcohol moiety of a compound of Formula IV, wherein said protection is characterized by the use of acidic catalysis controlled by left over acid from phosphorous oxychloride from the previous reaction and an ether selected from the group consisting of: 2-methoxy-1-propene, dihydropyran, methyl vinyl ether, ethyl vinyl ether, and 5,6-dihydro-4-methoxy-2H-pyran
Data Source
AI summary
The present invention relates to a process of preparing a compound of Formula I: (I) Formula I Wherein R1 is defined in the specification. Compounds of Formula I are useful for treating disorders of the central nervous system, including epilepsy. The process includes a novel use of the reagent lithium borohydride.